FDA Phase / Person Communication and Meetings / / /
IndustryTerm
federal law enforcement / law enforcement / appropriate ancillary services / local law enforcement / /
MedicalCondition
immediate opiate addiction / Opiate Addiction / /
MedicalTreatment
counseling / /
Organization
American Psychiatric Association / FDA / PRIVACY ACT INFORMATION Authority / American Board of Medical Specialties / American Osteopathic Association / American Society of Addiction Medicine / American Academy of Addiction Psychiatry / Substance Abuse and Mental Health Services Administration Division of Pharmacologic Therapies Attention / Drug Enforcement Administration / American Medical Association / / /
Position
investigator / physician / SAMHSA Reports Clearance Officer / SAMHSA Buprenorphine Physician / Secretary / Secretary and the Attorney General / qualifying physician / /
Notification of Intent to Use Schedule III, IV, or V Opioid Drugs for the Maintenance and Detoxification Treatment of Opiate Addiction, SMA-167